SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 3.010-2.3%Jan 20 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan Spillane who wrote (1698)3/18/1999 3:56:00 PM
From: Anthony Wong  Read Replies (1) of 2539
 
Analysts comments re. the Zeneca/Monsanto agreement:

''The companies save legal expenses, and it opens up the
market a little bit because farmers will now be able to use
either Touchdown or Roundup on Roundup Ready seeds,'' said Fred
Siemer, an independent analyst in New York.

''This is basically a compromise that allows both companies
to avoid further court action,'' said Steve Abbott, an analyst at
Credit Lyonnais Securities in London.

Monsanto said sales for Roundup increased by 25 percent in
1998 from a year earlier. Abbott estimated that Roundup generated
about a quarter of Monsanto's $8.6 billion in 1998 sales.

''It allows Monsanto to further leverage its Roundup
technology before the patent expires,'' said Siemer.

news.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News